Shelter Pharma Share Price Today

Shelter Pharma H1FY27 Results: Net profit up 15.4% to ₹5.2 crore

Revenue from operations rose 35.6% YoY to ₹4,513.22 lakh in H1FY27. Net profit increased 15.4% YoY to ₹520.61 lakh, despite margin pressure. Exports reached ₹61.1 million, accounting for 13.5% of total revenue. Receivable days improved to 47 days from 59 days in March 2026. Company plans second plant with capacity for ₹1,000 million annual revenue.

Shelter Pharma shareholders approve Vinita Gadhavi as independent director

Shareholders approved Vinita Shivraj Gadhavi as Non-Executive Independent Director. Term fixed for 5 years from July 31, 2026 to July 30, 2031. Director not liable to retire by rotation during tenure. All seven AGM resolutions passed unanimously on September 29, 2026.

Shelter Pharma receives positive doctor reviews for healthcare products

Shelter Pharma received positive reviews from Dr. C.M. Patel for three products. Endorsed items include Lemonade Barley Water, Alkaliser syrup, and Joemega capsules. Feedback highlights natural composition and benefits for children's growth. Company filed voluntary disclosure under SEBI Regulation 30 with no immediate financial impact.

Shelter Pharma secures Rs 9.72 lakh order from Berlin International Company

Shelter Pharma secured a new order worth Rs 9.72 lakh from Berlin International Company for the supply of D3 CURE 50 ML. The company has disclosed 11 orders over the last three fiscal quarters, including major wins from Verka Dairy Ludhiana and Al-Saqr Agro. Total order inflow for Q2FY27 stands at Rs 212149.40 crore, while Q1FY27 recorded Rs 141684.45 crore. Trailing twelve-month revenue is reported as Rs 0.0 Cr, indicating a lag in revenue recognition relative to order bookings. The stock trades at a P/E of 6.6x with an ROCE of 15.97% as of September 22, 2026.

Shelter Pharma to showcase products at Jaipur Ayurveda exhibition in September

Shelter Pharma will exhibit at the Vishwa Ayurveda Parishad Exhibition in Jaipur. The event takes place on September 17 and 18, 2026. Company aims to strengthen ties with Ayurveda physicians and scholars. Participation aligns with long-term brand visibility strategy.

Shelter Pharma reschedules 19th AGM to September 28, 2026

Shelter Pharma reschedules its 19th AGM to September 28, 2026, from the previously announced September 29 date. Remote e-voting window remains unchanged: September 26 to September 28, 2026. Board regularizes Vinita Gadhavi as independent director for five years, effective July 31, 2026. Mrs. Parvezbanu Idariya offers herself for re-appointment after retiring by rotation.